Sometimes people’s bodies don’t produce enough growth hormone on their own. This is called growth hormone deficiency. When this happens, both children and adults may be treated with man-made growth hormone called recombinant human growth hormone. This hormone is identical to the growth hormone that human bodies make.

Norditropin® (somatropin [rDNA origin] injection) is one of these therapies, and it’s often prescribed for several growth-related conditions. It’s used to treat:

  • Children who are not growing because of low or no growth hormone
  • Children who are short (in stature) and who have Noonan syndrome or Turner syndrome
  • Children who are short (in stature) because they were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
  • Adults who did not make enough growth hormone when they were children or when they became adults

Growth hormone has an important job.

What is growth hormone? A role of growth hormone is to tell organs, tissues, and other parts of the body to grow. Knowing exactly how it functions in the body will help you understand the mechanics of treatment with Norditropin®.

How It Works

What about safety?

The safety of your child is always foremost in your mind. The safety profile of Norditropin® has been established in many clinical studies. We’ve got the information you need on safety, side effects, and risk factors.

Safety & Side Effects

What to expect.

Of course you’re curious about what’s next — how soon you might see the therapy begin to take effect, how much growth you might expect, and how long the treatment will last. These questions will be addressed by your doctor, and the answers will vary depending on several factors specific to your family. We’ll explain what these are so you can set reasonable expectations and goals.

See Results

Logan–Norditropin® patient, age 10 Logan–Norditropin® patient, age 10

A proven history.

We’re no newcomer to the world of growth hormone–replacement therapy. Novo Nordisk has been helping patients with growth-related hormone disorders around the world for 40 years, and Norditropin® has been FDA-approved in the United States since 1995. Find quick facts about our history, milestones, and our commitment to the growth hormone therapy community.

Track Record

Here to help.

Find out more about how NordiCare® can help you. For questions about your prescription, please contact your health care provider.

Contact NordiCare®